Advanced Breast Cancer
09
Sep
Subtype: HER2-Negative
Phase II, Single Arm, Open Label, Simon Two-Stage Study of Pembrolizumab in Metastatic HER2-negative Breast Can...
Early Breast Cancer
23
Jul
A Phase III, Randomized, open labelled, multicenter study evaluating the efficacy and safety of adjuvant giredestrant compared with p...